RE: Help required...13 Dec 2021 00:09
I wouldn’t be too concerned about the falling share price at the moment. We know a buyout is on the cards and the buyout price will be based on the company valuation that is underway. However, a low share price might be good for publicity of the company as the premium at buyout wld appear huge..so I’m not sure if someone is selling a few shares now and again to drop the share price deliberately. The last price targets I know of are of 310p & 349p from Liberum & P.Hunt respectively. I’m not expecting the buyout price to be around 300p but surely it wouldn’t be too far away from this. I’m hoping it will be 175+.
Regarding ownership structure, I don’t think private investors own much of this company. Drayson et al increased their holding to 24.63 recently. Funny enough, HSBC reduced their holding to below 1% recently as well. When I did the maths for the declared holdings by institutional investors holding 1% plus, I got 80.25% including NHS trusts. Now if we consider institutional investors holding less than 1%, I don’t think we will be left with much held by private players. And with a firebrand activist investor like Gatemore, I do believe we will get a decent deal. The RNS said they will be considering other options, in my view, it’s either a buyout then relisting in the USA or a secondary listing in the USA.
I have been in Sensyne since 2019 and I hv bought and sold a few times but I do have a huge holding here. I have also been topping up recently, the last being last week as I believe a premium is inevitable if the buyout goes ahead. If if fails to go ahead I think a secondary listing in the States will happen. Either of the options have potential for a good return, and I see the chances of the company going under to be very slim considering that it’s debt free.